Basilea Pharmaceutica AG (BSLN) — Cash Flow Reinvestment Rate
Basilea Pharmaceutica AG (BSLN) has a Cash Flow Reinvestment Rate of 0.06x as of December 2025, reinvesting CHF2.30 Million (capex CHF2.30 Million ) from operating cash flow of CHF39.03 Million. Explore Basilea Pharmaceutica AG (BSLN) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Basilea Pharmaceutica AG Cash Flow Reinvestment Rate (2005–2025)
Historical reinvestment intensity for Basilea Pharmaceutica AG across 8 annual periods. Also explore Basilea Pharmaceutica AG (BSLN) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Basilea Pharmaceutica AG (2005–2025)
Year-by-year capital reinvestment analysis for Basilea Pharmaceutica AG. For live market cap and broader valuation context, see how much is Basilea Pharmaceutica AG worth.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.04x | CHF2.62 Million | CHF62.09 Million | CHF2.62 Million | ▲ +15.3% |
| 2024 | 0.04x | CHF2.72 Million | CHF74.36 Million | CHF1.71 Million | ▼ -74.8% |
| 2023 | 0.15x | CHF2.07 Million | CHF14.24 Million | CHF1.03 Million | ▼ -98.9% |
| 2022 | 13.46x | CHF94.95 Million | CHF7.06 Million | CHF3.30 Million | ▲ +321.5% |
| 2017 | 3.19x | CHF60.71 Million | CHF19.01 Million | CHF711.00K | ▲ +35705.9% |
| 2012 | 0.01x | CHF1.32 Million | CHF148.17 Million | CHF1.32 Million | ▼ -23.3% |
| 2010 | 0.01x | CHF1.24 Million | CHF106.64 Million | CHF1.24 Million | ▼ -66.7% |
| 2005 | 0.03x | CHF1.20 Million | CHF34.38 Million | CHF1.20 Million | — |